National Asset Management, Inc. Abb Vie Inc. Transaction History

National Asset Management, Inc.

$4.29 Billion
Q1 2024

A detailed history of National Asset Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, National Asset Management, Inc. holds 145,412 shares of ABBV stock, worth $24.9 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

145,412

Previous 130,219 11.67%

Holding current value

$24.9 Million

Previous $20.2 Million 31.21%

% of portfolio

0.62%

Previous 0.55%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 16, 2024	BUY	$159.82 - $182.1 $2.43 Million - $2.77 Million	15,193 Added 11.67%	145,412 $26.5 Million
Q4 2023 Mar 15, 2024	SELL	$137.6 - $154.97 $2.09 Million - $2.35 Million	-15,193 Reduced 10.45%	130,219 $20.2 Million
Q3 2023 Dec 01, 2023	SELL	$133.59 - $154.65 $2.89 Million - $3.35 Million	-21,652 Reduced 12.96%	145,412 $21.7 Million
Q2 2023 Jul 27, 2023	SELL	$132.51 - $164.9 $2.08 Million - $2.59 Million	-15,708 Reduced 8.59%	167,064 $22.5 Million
Q1 2023 May 17, 2023	SELL	$144.61 - $166.54 $1.11 Million - $1.28 Million	-7,680 Reduced 4.03%	182,772 $29.1 Million

Q4 2022 Mar 15, 2023	SELL	$138.31 - $165.87 $193,634 - $232,218	-1,400 Reduced 0.73%	190,452 $30.8 Million
Q4 2022 Feb 21, 2023	BUY	$138.31 - $165.87 $1 Million - $1.2 Million	7,260 Added 3.93%	191,852 $31 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $9.34 Million - $10.7 Million	69,566 Added 60.48%	184,592 $24.8 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $1.76 Million - $2.24 Million	-12,824 Reduced 10.03%	115,026 $17.6 Million
Q1 2022 May 02, 2022	BUY	$131.98 - $163.75 $12,010 - $14,901	91 Added 0.07%	127,850 $20.7 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $212,926 - $269,413	1,982 Added 1.58%	127,759 $17.3 Million
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $982,391 - $1.12 Million	9,233 Added 7.92%	125,777 $13.6 Million
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $878,398 - $978,586	8,349 Added 7.72%	116,544 $13.1 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $4.4 Million - $4.84 Million	42,965 Added 65.87%	108,195 $11.7 Million
Q4 2020 Feb 04, 2021	SELL	$80.49 - $108.67 $1.23 Million - $1.66 Million	-15,247 Reduced 18.95%	65,230 $6.99 Million
Q3 2020 Nov 09, 2020	BUY	$85.91 - $100.83 $117,095 - $137,431	1,363 Added 1.72%	80,477 $7.07 Million
Q2 2020 Jul 31, 2020	BUY	$73.37 - $98.18 $1.02 Million - $1.37 Million	13,970 Added 21.44%	79,114 $7.68 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $667,639 - $1.01 Million	10,351 Added 18.89%	65,144 $4.96 Million
Q4 2019 Feb 10, 2020	BUY	$72.13 - $90.25 $802,085 - $1 Million	11,120 Added 25.46%	54,793 $4.85 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $1.28 Million - $1.54 Million	20,307 Added 86.91%	43,673 $3.31 Million
Q2 2019 Aug 05, 2019	BUY	$65.7 - $83.98 $52,757 - $67,435	803 Added 3.56%	23,366 $1.7 Million
Q1 2019 May 08, 2019	BUY	$77.14 - $90.79 $339,801 - $399,929	4,405 Added 24.26%	22,563 $1.82 Million
Q4 2018 Feb 08, 2019	SELL	$77.85 - $96.01 $147,603 - $182,034	-1,896 Reduced 9.45%	18,158 $1.68 Million
Q3 2018 Nov 08, 2018	SELL	$88.91 - $98.84 $62,948 - $69,978	-708 Reduced 3.41%	20,054 $1.9 Million
Q2 2018 Oct 05, 2018	BUY	$89.78 - $106.23 $63,115 - $74,679	703 Added 3.5%	20,762 $1.93 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $707,188 - $946,992	-7,686 Reduced 27.7%	20,059 $1.9 Million
Q4 2017 Feb 15, 2018	BUY	$89.56 - $98.21 $139,176 - $152,618	1,554 Added 5.93%	27,745 $2.68 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $40,722 - $52,015	-583 Reduced 2.18%	26,191 $2.33 Million
Q2 2017 Aug 15, 2017	BUY	N/A	26,774	26,774 $1.94 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.

Account

National Asset Management, Inc. Abb Vie Inc. Transaction History